UNLOCKING

CARDIOLOGY

IMMUNOLOGY

HEaLTHCARE

Life

We aim to create a lasting and meaningful impact on patients suffering from cardiac conditions.

Cardiovascular diseases are a major burden and the first cause of death globally.

18+

Millions
deaths/year

85%

caused by myocardial infarction
& stroke

300

millions Disability-adjusted
life years (DALY)

We unlock the potential of immunotherapies to reshape the future of Cardiovascular care.
The momentum around emerging Cardio-immunology field has never been stronger.

Our revolution

We design monoclonal antibodies that specifically target the immune system's inflammatory pathways to prevent occurence and worsening of cardiovascular diseases.

We aim to drastically reduce the burden of cardiovascular diseases by developing preventing immunotherapies targeting their inflammatory root causes.

Polygon is built on the high-impact academic work of Prof. Ait-Oufella, published in top-tier journals and primed for clinical translation. Led by skilled team with complementary expertise and backed by a scientific advisory board at the forefront of cardiology and inflammation, we are committed to turning breakthrough science into treatments that reach patients

Let's unite